Acumen pharmaceuticals, inc. ABOS.US AI Analysis
BetaUS StockHealthcare
(No presentation for ABOS)
ABOS Value Score
3
24
15
Poor Growth
Analysis Conclusion
The stock has a low value rating. If your investment strategy is value-oriented and you have long-term positions, it's crucial to adhere to your exit plan and consider reducing holdings.
ABOS Value Strategy Backtest
The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.
Entry
Exit
The Backtest Result of ABOS from 2021-07-01 till Now
- -
- Cumulative Return
- -
- Annual Return
- -
- Volatility
- -
- Sharpe Ratio
Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from July, 2021 to June, 2025. (Total Trades: 0)
| ABOS | Sector | US Overall Market | |
|---|---|---|---|
| Wining Rate | - | 47% | 57% |
| Avg Return | - | 47.2% | 60.6% |
| Avg Profit | - | 147.5% | 131.4% |
| Avg Loss | - | -40.5% | -32% |
| Avg Risk-Reward Ratio | - | 364.3% | 410.1% |